Related Experiment Video
Updated: May 5, 2026
09:01
Chronic Salmonella Infected Mouse Model
Published on: May 31, 2010
16.9K
Helicobacter and salmonella persistent infection strategies
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305.
Cold Spring Harbor Perspectives in Medicine
|December 4, 2013
Summary
This review compares Helicobacter pylori and Salmonella Typhi, exploring their strategies for lifelong persistence in human hosts. Understanding these bacterial survival tactics in chronic carriers can inform new treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Host-Pathogen Interactions
Background:
- Certain bacteria, like Helicobacter pylori and Salmonella enterica serovar Typhi, establish persistent infections in humans.
- These pathogens can lead to lifelong colonization, with infected individuals acting as reservoirs.
Purpose of the Study:
- To compare and contrast the lifestyles and persistence strategies of Helicobacter pylori and Salmonella Typhi within mammalian hosts.
- To investigate how chronic carrier states contribute to bacterial survival and identify potential therapeutic targets.
Main Methods:
- Comparative analysis of host-pathogen interactions.
- Review of established bacterial persistence mechanisms.
- Examination of epidemiological data on chronic carrier states.
Main Results:
- Helicobacter pylori colonizes the gastric mucosa, often for life.
- Salmonella Typhi causes systemic infections and can result in lifelong carriage.
- Both pathogens utilize distinct strategies to maintain long-term presence within hosts.
Conclusions:
- Persistently infected carriers are crucial reservoirs for these bacterial pathogens.
- Studying chronic carriage offers insights into bacterial survival strategies.
- Understanding these mechanisms may lead to novel therapeutic interventions for persistent infections.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
01:26Gastritis II: Pathophysiology
87
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
87
01:25Colonisation of Pathogens
80
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
80
01:26Peptic Ulcer Disease IV: Management
815
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
815
01:23Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
01:30Reservoir of Infection
103
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
103